3.4 Creating JMP Scripts and Add-Ins
3.4.1 New Discontinuation Variables and Risk Thresholds
My attempt to create
reasonably-sized data tables of risk indicators resulted in 61 and
55 variables for the site- and country-level data tables, respectively,
for the study Nicardipine. Despite this
generous set of variables, users continually ask for new and varied
ways of summarizing their data for RBM analysis and review. This
is to be expected: No two clinical trials are the same, no two study
teams are the same, and no two pharmaceutical companies are the same.
The functionality in Update Study Risk Data Set is one way of generating new risk indicators for data that is typically not captured as part of the study database by averaging by randomized ...
Get Risk-Based Monitoring and Fraud Detection in Clinical Trials Using JMP and SAS now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
